Russell Investments Group, Ltd. Harpoon Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$7.88 - $14.0 $99,571 - $176,904	-12,636 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$17.65 - $24.16 $101,487 - $138,920	-5,750 Reduced 31.27%	12,636 $264,000
Q4 2020 Feb 08, 2021	SELL	$12.83 - $17.84 $225,641 - $313,752	-17,587 Reduced 48.89%	18,386 $304,000
Q3 2020 Nov 09, 2020	BUY	$11.01 - $18.52 $139,122 - $234,018	12,636 Added 54.15%	35,973 $608,000
Q2 2020 Aug 05, 2020	BUY	$11.11 - $24.72 $17,287 - $38,464	1,556 Added 7.14%	23,337 $386,000
Q1 2020 May 06, 2020	BUY	$10.74 - $16.32 $5,864 - $8,910	546 Added 2.57%	21,781 $251,000
Q4 2019 Jan 29, 2020	BUY	$12.94 - $20.58 $274,780 - $437,016	21,235 New	21,235 $315,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.